MyFinsight
Home
Compare
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
|
Compare
Income Overview
Net Income
-$18,603K
EPS
-$2.51
Unit: Thousand (K) dollars
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Income Statement
2026-06-30
Research and development (includes related party amounts of 389 and 6,389 for the three and six months ended june30, 2026, respectively)
11,125
In-process research and development
0
General and administrative (includes nominal related party amounts for the three and six months ended june30, 2026, respectively)
4,757
Total operating expenses
15,882
Loss from operations
-15,882
Interest income
889
Other income
5
Total other income
894
Net loss
-14,988
Less deemed dividend to preferred stockholders
3,615
Net loss attributed to common stockholders
-18,603
Net loss attributed to common stockholders
-18,603
Basic EPS
-2.51
Diluted EPS
-2.51
Basic Average Shares
7,401,783
Diluted Average Shares
7,401,783
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Income Statement
Net loss attributed
to common...
-$18,603K
Net loss attributed
to common...
-$18,603K
Interest income
$889K
Other income
$5K
Net loss
-$14,988K
Less deemed dividend
to preferred...
$3,615K
Total other income
$894K
Loss from operations
-$15,882K
Total operating
expenses
$15,882K
Research and development
(includes related party...
$11,125K
General and
administrative (includes...
$4,757K
Buy us a coffee
Braveheart Bio, Inc. (BRVE)
Braveheart Bio, Inc. (BRVE)